Results 111 to 120 of about 14,994 (217)
Effect of Iron/Folic Acid Supplementation on the Outcome of Malaria Episodes Treated with Sulfadoxine-Pyrimethamine [PDF]
Folic acid supplementation may potentially alter the efficacy of sulfadoxine-pyrimethamine (SP) treatment in children with malaria. However, there is lack of evidence fromrandomized controlled trials and effects of folic acid supplementation on clinical ...
Kabole, Ibrahim +11 more
core
In Rwanda, amodiaquine+sulfadoxine/pyrimethamine (AQ+SP) is the current first-line treatment for malaria, introduced in 2001 as an interim strategy before the future deployment of an artemisinin-based combination treatment (ACT).
van Overmeir, C +22 more
core +1 more source
Background: Cameroon bears a high malaria burden, and sulfadoxine–pyrimethamine (SP) remains widely used for intermittent preventive treatment in pregnancy despite the adoption of artemisinin-based combination therapies.
Guela Djoukou Mba Edna +12 more
doaj +1 more source
Objective: To determine and compare the in vivo efficacy of the trial drugs chloroquine and sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in under 5 children.
Henrietta U Okafor, Tagbo Oguonu
doaj
We studied (in 1998 and 1999) some factors that may be linked to the spread of chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) resistance in 7 discrete communities in Uganda.
Watkins, W +15 more
core +1 more source
BackgroundMalaria in pregnancy (MiP) is a condition that can be prevented by using intermittent preventive treatment using Sulfadoxine-pyrimethamine. However, despite all the effort to reduce the consequences of MiP for the woman, the unborn child, and ...
Livingstone Asem +3 more
doaj +1 more source
A need for new tools for prevention of malaria in pregnancy.
Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is a chemoprevention strategy against malaria in pregnancy. A recent PLOS Medicine study highlights the need for better understanding of the mechanism by which IPTp-
Makoto Saito, Rose McGready
doaj +1 more source
Differences in willingness to pay for artemisinin-based combinations or monotherapy: experiences from the United Republic of Tanzania. [PDF]
OBJECTIVE: The cost of combination treatment is thought to be one of the greatest barriers to their deployment, but this has not been tested directly.
Mutabingwa, Theonest K +9 more
core
Através da prova de 7 dias foram estudadas as respostas terapêuticas de 96 pacientes com malária falciparum não grave atendidos pela SUCAM em Imperatriz, Maranhão.
Afonso Dinis Costa Passos +2 more
doaj
[Plasmodium falciparum resistant to sulfadoxine/pyrimethamine in Senegal].
In 1983, the first African cases of malaria due to Plasmodium falciparum resistant to sulfadoxine/pyrimethamine, were described. Currently, this resistance is frequently found in Kenya and Tanzania. It has also been described in other African countries.
J, Botella de Maglia +3 more
openaire +1 more source

